Please assess the completion status of the following clinical trial:

Trial Title: Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Blood pressure: 120mmHg≤SBP\<160mmHg, and/or 80mmHg≤DBP\<100mmHg~Exclusion Criteria:~* Diabetes~* Hypertension: SBP≥160mmHg, or DBP≥100mmHg~* known allergy to trial drugs~* Myocardial infarction or cerebrovascular accident in the year preceding the trial~* Clinical Congestive Heart Failure~* Secondary hypertension~* Pregnancy or lactating women~* Malignant tumor~* Gastroesophageal reflux or gastroduodenal ulcer~* History of hepatitis or cirrhosis~* History of kidney disease~* Body weight﹤35Kg

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Menthol (Type: ACTIVE_COMPARATOR): Interventions Drug: Menthol Arms: Group 1
- Placebo (Type: PLACEBO_COMPARATOR): Interventions Drug: Placebo Arms: Group 2

Based on this trial design, predict the completion outcome and termination type (if applicable).